Biblio
“Alzheimer's Disease Progression: Factors Influencing Cognitive Decline.”, J Alzheimers Dis, vol. 61, no. 2, pp. 785-791, 2018.
, “Alzheimer's Disease: Recent Concepts on the Relation of Mitochondrial Disturbances, Excitotoxicity, Neuroinflammation, and Kynurenines.”, J Alzheimers Dis, vol. 62, no. 2, pp. 523-547, 2018.
, “Alzheimer's disease risk gene CD33 inhibits microglial uptake of amyloid beta.”, Neuron, vol. 78, no. 4, pp. 631-43, 2013.
, “Alzheimer's Disease Risk Genes and Lipid Regulators.”, J Alzheimers Dis, vol. 53, no. 1, pp. 15-29, 2016.
, “Alzheimer's Disease rs11767557 Variant Regulates EPHA1 Gene Expression Specifically in Human Whole Blood.”, J Alzheimers Dis, vol. 61, no. 3, pp. 1077-1088, 2018.
, “Alzheimer's Disease Severity is Not Significantly Associated with Short Sleep: Survey by Actigraphy on 208 Mild and Moderate Alzheimer's Disease Patients.”, J Alzheimers Dis, vol. 55, no. 1, pp. 321-331, 2017.
, “Alzheimer's Disease: The Alternative Serotonergic Hypothesis of Cognitive Decline.”, J Alzheimers Dis, vol. 60, no. 3, pp. 859-866, 2017.
, “Alzheimer's Disease, Visual Search, and Instrumental Activities of Daily Living: A Review and a New Perspective on Attention and Eye Movements.”, J Alzheimers Dis, vol. 66, no. 3, pp. 901-925, 2018.
, “Alzheimer's Disease with Epileptiform EEG Activity: Abnormal Cortical Sources of Resting State Delta Rhythms in Patients with Amnesic Mild Cognitive Impairment.”, J Alzheimers Dis, vol. 88, no. 3, pp. 903-931, 2022.
, “Alzheimer's Disease-Associated Cerebrospinal Fluid (CSF) Biomarkers do not Correlate with CSF Volumes or CSF Production Rate.”, J Alzheimers Dis, vol. 58, no. 3, pp. 821-828, 2017.
, “Alzheimer's Disease-Like Neurodegeneration in Porphyromonas gingivalis Infected Neurons with Persistent Expression of Active Gingipains.”, J Alzheimers Dis, vol. 75, no. 4, pp. 1361-1376, 2020.
, “Alzheimer's Disease-Related Neuropathology Among Patients with Medication Treated Type 2 Diabetes in a Community-Based Autopsy Cohort.”, J Alzheimers Dis, vol. 83, no. 3, pp. 1303-1312, 2021.
, “Alzheimer's Disease-Related Polymorphisms in Shunt-Responsive Idiopathic Normal Pressure Hydrocephalus.”, J Alzheimers Dis, vol. 60, no. 3, pp. 1077-1085, 2017.
, “Alzheimer's/Vascular Spectrum Dementia: Classification in Addition to Diagnosis.”, J Alzheimers Dis, vol. 73, no. 1, pp. 63-71, 2020.
, “Amsterdam Dementia Cohort: Performing Research to Optimize Care.”, J Alzheimers Dis, vol. 62, no. 3, pp. 1091-1111, 2018.
, “Amygdala α-Synuclein Pathology in the Population-Based Vantaa 85+ Study.”, J Alzheimers Dis, vol. 58, no. 3, pp. 669-674, 2017.
, “Amylin Enhances Amyloid-β Peptide Brain to Blood Efflux Across the Blood-Brain Barrier.”, J Alzheimers Dis, vol. 56, no. 3, pp. 1087-1099, 2017.
, “Amylin Treatment Reduces Neuroinflammation and Ameliorates Abnormal Patterns of Gene Expression in the Cerebral Cortex of an Alzheimer's Disease Mouse Model.”, J Alzheimers Dis, vol. 56, no. 1, pp. 47-61, 2017.
, “Amyloid Accumulation and Cognitive Decline in Clinically Normal Older Individuals: Implications for Aging and Early Alzheimer's Disease.”, J Alzheimers Dis, vol. 64, no. s1, pp. S633-S646, 2018.
, “Amyloid and FDG PET of Successful Cognitive Aging: Global and Cingulate-Specific Differences.”, J Alzheimers Dis, vol. 66, no. 1, pp. 307-318, 2018.
, “Amyloid Burden in Obstructive Sleep Apnea.”, J Alzheimers Dis, vol. 59, no. 1, pp. 21-29, 2017.
, “Amyloid Deposition Is Greater in Cerebral Gyri than in Cerebral Sulci with Worsening Clinical Diagnosis Across the Alzheimer's Disease Spectrum.”, J Alzheimers Dis, vol. 83, no. 1, pp. 423-433, 2021.
, “Amyloid Hypothesis: The Emperor's New Clothes?”, J Alzheimers Dis, vol. 78, no. 4, pp. 1363-1366, 2020.
, “Amyloid Plaques Show Binding Capacity of Exogenous Injected Amyloid-β.”, J Alzheimers Dis, vol. 55, no. 1, pp. 147-157, 2017.
, “The Amyloid, Tau, and Neurodegeneration (A/T/N) Classification Applied to a Clinical Research Cohort with Long-Term Follow-Up.”, J Alzheimers Dis, vol. 74, no. 3, pp. 829-837, 2020.
,